What can we do for you?
No. 2 on the A-List 2024
Ropes & Gray has been ranked No. 2 on The American Lawyer’s A-List—our 13th consecutive year on the A-List.
The American Lawyer’s 2024 Pharma and Health Care Corporate Practice of the Year
Ropes & Gray’s life sciences and healthcare teams delivered exceptional results for clients, steering transformative deals and facilitating over 110 complex licensing and collaboration transactions with an aggregate value of $55 billion.
Latest Insights
Alert
Executive Order Calls for Most-Favored-Nation Pharmaceutical Pricing for American Patients
On May 12, 2025, President Trump issued an executive order directing executive agencies and, imminently, pharmaceutical manufacturers to take steps to deliver most-favored-nation prescription drug pricing to patients in the United States.
Alert
Department of Justice Announces Changes to Corporate Enforcement Policies; More Carrots and Sticks
Alert
New York Fails to Pass Expanded Health Care Transaction Notice Requirements Bill
On May 9, 2025, New York State (“NYS”) Governor Kathy Hochul signed legislation enacting the State Fiscal Year 2025-26 budget into law.
Alert
Insights from the Third Annual Ropes & Gray Rare Disease Forum
Ropes & Gray recently hosted its Third Annual Ropes & Gray Rare Disease Forum on May 1, 2025 in Cambridge, Massachusetts.

United in the Fight Against Cancer
Through our work with clients, public service and support of our own community, Ropes & Gray is committed to the battle against cancer.
Practice with Purpose
We are committed to fostering a welcome community where all professionals of all backgrounds can reach their full potential, and giving back to our broader community by providing the highest level of pro bono legal advice and support to those who need it most.
Ropes & Gray
by the numbers
0+
Attorneys worldwide
0
Offices
0+
2024 pro bono hours
0
Consecutive years on A-List of elite firms
